BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 41 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,534,080 | -48.1% | 67,223,000 | -57.4% | 1.74% | -37.0% |
| Q2 2023 | $124,241,221 | +0.1% | 157,723,000 | -5.8% | 2.76% | -5.4% |
| Q1 2023 | $124,078,968 | +75.8% | 167,448,000 | +6.8% | 2.91% | +106.1% |
| Q4 2022 | $70,578,450 | -24.5% | 156,841,000 | +0.4% | 1.41% | -13.0% |
| Q3 2022 | $93,497,000 | +20.9% | 156,141,000 | +11.8% | 1.62% | +17.2% |
| Q2 2022 | $77,333,000 | +28.6% | 139,641,000 | +39.3% | 1.39% | +27.3% |
| Q1 2022 | $60,134,000 | – | 100,224,000 | – | 1.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 141,500,000 | $63,675,000 | 2.13% |
| ARISTEIA CAPITAL, L.L.C. | 156,841,000 | $70,578,450 | 1.41% |
| Affinity Asset Advisors, LLC | 7,500,000 | $3,410,048 | 1.34% |
| CONTRARIAN CAPITAL MANAGEMENT, L.L.C. | 8,500,000 | $3,782,500 | 0.94% |
| TFG Asset Management GP Ltd | 10,000,000 | $4,623,611 | 0.66% |
| Context Capital Management, LLC | 17,035 | $7,890 | 0.58% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 47,329,000 | $18,813 | 0.52% |
| SILVERBACK ASSET MANAGEMENT LLC | 5,000,000 | $2,287,850 | 0.32% |
| MACKAY SHIELDS LLC | 14,611,000 | $6,574,950 | 0.17% |
| Ionic Capital Management LLC | 1,400,000 | $644,740 | 0.15% |